Latest filings (excl ownership)
15-12G
Securities registration termination
4 Oct 23
8-K
Bankruptcy or Receivership
25 Sep 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
29 Jun 23
8-K
Other Events
12 Jun 23
NT 10-Q
Notice of late quarterly filing
16 May 23
8-K
Entry into a Material Definitive Agreement
24 Apr 23
8-K
Entry into a Material Definitive Agreement
18 Apr 23
NT 10-K
Notice of late annual filing
13 Apr 23
25-NSE
Exchange delisting
12 Apr 23
8-K
Other Events
10 Apr 23
8-K
Other Events
5 Apr 23
8-K
Lucira Health Announces Fda Authorization of FirstĀ & Only At-home Combination COVID-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing
27 Feb 23
8-K
Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
22 Feb 23
8-K
Departure of Directors or Certain Officers
21 Feb 23
8-K
Departure of Directors or Certain Officers
13 Jan 23
8-K
Termination of a Material Definitive Agreement
28 Dec 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
19 Dec 22
8-K
Departure of Directors or Certain Officers
15 Dec 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates
14 Nov 22
8-K
Other Events
1 Nov 22
8-K
Departure of Directors or Certain Officers
26 Oct 22
8-K
Departure of Directors or Certain Officers
22 Sep 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K
Lucira Health Announces Second Quarter 2022 Results and Provides Business Updates
15 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 22
10-Q
2022 Q1
Quarterly report
13 May 22
8-K
Lucira Health Announces First Quarter 2022 Results and Business Update
12 May 22
DEFA14A
Additional proxy soliciting materials
20 Apr 22
DEF 14A
Definitive proxy
20 Apr 22
S-8
Registration of securities for employees
11 Apr 22
10-K
2021 FY
Annual report
31 Mar 22
8-K
Termination of a Material Definitive Agreement
14 Mar 22
8-K
Lucira Health Announces Fourth Quarter and Full Year 2021 Results and Reaffirms 2022 Financial Outlook
10 Mar 22
8-K
Lucira Health Secures Debt Facility of Up to $80 Million from Hercules Capital and Silicon Valley Bank
8 Feb 22
8-K
Lucira Health Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021 and Provides Business Update
10 Jan 22
8-K
Lucira Health and Co-Defend/Co-Protect Announce Expanded Partnership for 2022
29 Dec 21
8-K
Regulation FD Disclosure
23 Dec 21
Latest ownership filings
4
Erik T. Engelson
13 Mar 23
4
Richard Clavano Narido
13 Mar 23
4
Kevin Walter Collins
13 Mar 23
4
Anthony Joseph Allen
13 Mar 23
4
Ghazi Kashmolah
21 Feb 23
SC 13D/A
EPIQ Capital Group, LLC
22 Dec 22
4
Anthony Joseph Allen
22 Dec 22
4
Chad Boeding
16 Dec 22
4
Anthony Joseph Allen
9 Dec 22
4
Ghazi Kashmolah
9 Dec 22
4
Ghazi Kashmolah
9 Dec 22
4
Richard Clavano Narido
6 Dec 22
4
Kevin Walter Collins
29 Nov 22
3
Richard Clavano Narido
25 Nov 22
4
Ghazi Kashmolah
18 Nov 22
4
Anthony Joseph Allen
22 Sep 22
4
Dan George
20 Sep 22
4
Erik T. Engelson
19 Sep 22
4
Debkishore Mitra
6 Sep 22
4
Kevin Walter Collins
29 Aug 22
4
Ghazi Kashmolah
29 Aug 22
4/A
Ghazi Kashmolah
24 Aug 22
4
Ghazi Kashmolah
19 Aug 22
4
Debkishore Mitra
12 Jul 22
4
Tamanna Prashar
12 Jul 22
4
Kevin Walter Collins
12 Jul 22
4
Dan George
12 Jul 22
4
Erik T. Engelson
17 Jun 22
4
Tuff Yen
3 Jun 22
4
Steve Tablak
3 Jun 22
4
Lior Susan
3 Jun 22
4
Erica J. Rogers
3 Jun 22
4
Alison McCauley
3 Jun 22
4
David Lamond
3 Jun 22
4
SANDRA A. GARDINER
3 Jun 22
4
Erik T. Engelson
16 Mar 22
4
Tamanna Prashar
14 Feb 22
SC 13G
Eclipse GP III, LLC
14 Feb 22
4
Alison McCauley
21 Dec 21
3
Alison McCauley
21 Dec 21